Cargando…
Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system
BACKGROUND: Statins are the cornerstone of pharmacotherapy for atherosclerotic cardiovascular disease. While these drugs are generally safe, treatment adherence is not optimal in a considerable proportion of patients because of the adverse effects on skeletal muscles in the forms of myopathy, myalgi...
Autores principales: | Sahebkar, Amirhossein, Cicero, Arrigo F.G., Di Giosia, Paolo, Pomilio, Irene, Stamerra, Cosimo Andrea, Giorgini, Paolo, Ferri, Claudio, von Haehling, Stephan, Banach, Maciej, Jamialahmadi, Tannaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567138/ https://www.ncbi.nlm.nih.gov/pubmed/32743965 http://dx.doi.org/10.1002/jcsm.12579 |
Ejemplares similares
-
Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies
por: Stamerra, Cosimo Andrea, et al.
Publicado: (2022) -
Effects of statins on mitochondrial pathways
por: Mollazadeh, Hamid, et al.
Publicado: (2021) -
Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants
por: Vahedian-Azimi, Amir, et al.
Publicado: (2021) -
Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
por: Stamerra, Cosimo A., et al.
Publicado: (2021) -
Statins and C-reactive protein: in silico evidence on direct interaction
por: Shakour, Neda, et al.
Publicado: (2020)